|
ZFP64 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.600300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.406000E-01 |
| Normal-vs-Stage2 |
3.019200E-01 |
| Normal-vs-Stage3 |
6.944200E-03 |
| Normal-vs-Stage4 |
3.817600E-01 |
| Stage1-vs-Stage2 |
2.168400E-01 |
| Stage1-vs-Stage3 |
6.515000E-03 |
| Stage1-vs-Stage4 |
3.649200E-01 |
| Stage2-vs-Stage3 |
1.475410E-01 |
| Stage2-vs-Stage4 |
9.733600E-01 |
| Stage3-vs-Stage4 |
2.366000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.122300E-02 |
| Normal-vs-AfricanAmerican |
5.590600E-01 |
| Normal-vs-Asian |
9.038600E-01 |
| Caucasian-vs-AfricanAmerican |
3.833000E-01 |
| Caucasian-vs-Asian |
7.480800E-01 |
| AfricanAmerican-vs-Asian |
9.222200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.791600E-01 |
| Normal-vs-Female |
3.56639999999908E-05 |
| Male-vs-Female |
1.9756599999976E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.221600E-01 |
| Normal-vs-Extreme_Weight |
4.840400E-01 |
| Normal-vs-Obese |
2.780000E-02 |
| Normal-vs-Extreme_Obese |
2.330800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.019570E-01 |
| Normal_Weight-vs-Obese |
6.200400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.637980E-01 |
| Extreme_Weight-vs-Obese |
1.298390E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.481200E-01 |
| Obese-vs-Extreme_Obese |
6.251700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.981570E-02 |
| Normal-vs-Age(41-60Yrs) |
1.630330E-02 |
| Normal-vs-Age(61-80Yrs) |
7.218200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.346200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.571500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.061550E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.038300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.639900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.344300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.524300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.507200E-01 |
| Normal-VS-Type2 PRCC |
2.887400E-01 |
| Normal-VS-KIRP CIMP |
9.139100E-03 |
| Normal-VS-Unclassified PRCC |
1.732020E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.608000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.18599999999292E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.513930E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.802300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.344580E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.766500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.496600E-01 |
| Normal-vs-N1 |
1.444410E-03 |
| Normal-vs-N2 |
6.547400E-01 |
| N0-vs-N1 |
2.044900E-03 |
| N0-vs-N2 |
6.766000E-01 |
| N1-vs-N2 |
2.534600E-01 |
|
|
